SCHEMBL7316537

SCHEMBL7316537

CCCCc1nc(=O)c(Cc2ccccc2)n[nH]1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 5/20 0.46
AR P10275 1/20 0.46
HPGD P15428 3/20 0.44
CYP2C9 P11712 2/20 0.44
ALDH1A1 P00352 2/20 0.44
APLNR P35414 1/20 0.44
POLB P06746 3/20 0.41
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41
ALPL P05186 4/20 0.40
DAO P14920 2/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40
NR1H2 P55055 1/20 0.40
NR1H3 Q13133 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
ALOX12 P18054 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6112477 0.78 ALPL (0.51) PARP1ARALDH1A1POLBHTT
SCHEMBL7318428 0.77 PARP1 (0.47) PARP1HPGDALDH1A1NPC1RAB9A
SCHEMBL7316543 0.74 POLB (0.54) PARP1HPGDCYP2C9ALDH1A1POLB
SCHEMBL7659167 0.74 PARP1 (0.46) PARP1POLBALPLDAONPC1
SCHEMBL11816798 0.73 PARP1 (0.53) PARP1ARHPGDCYP2C9ALDH1A1
SCHEMBL6007194 0.71 ALDH1A1 (0.42) PARP1HPGDALDH1A1POLBMEN1
SCHEMBL6004747 0.71 ALPL (0.46) PARP1ALDH1A1POLBALPLDAO
SCHEMBL7325204 0.71 MAPT (0.41) PARP1ALDH1A1
SCHEMBL1899895 0.70 NR1H2 (0.58) PARP1POLBLMNANR1H2NR1H3
SCHEMBL21634176 0.70 NR1H2 (0.46) HPGDALDH1A1POLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6071913-A 2-(1H-TETRAZOL-5-YL)-4'-(AS-TRIAZIN-YLMETHYL)BIPHENYLS; CARDIOVASCULAR DISEASES, ESPECIALLY HYPERTENSION AND CONGESTIVE HEART FAILURE DEVELOPMENT CENTER FOR BIOTECHNOLOGY (TW) 2000-06-06 US disclosed